JP2017536804A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017536804A5 JP2017536804A5 JP2017517301A JP2017517301A JP2017536804A5 JP 2017536804 A5 JP2017536804 A5 JP 2017536804A5 JP 2017517301 A JP2017517301 A JP 2017517301A JP 2017517301 A JP2017517301 A JP 2017517301A JP 2017536804 A5 JP2017536804 A5 JP 2017536804A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- virus
- amino acid
- biologically active
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462058961P | 2014-10-02 | 2014-10-02 | |
| US62/058,961 | 2014-10-02 | ||
| PCT/US2015/053385 WO2016054309A1 (en) | 2014-10-02 | 2015-10-01 | Influenza a virus variants |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017536804A JP2017536804A (ja) | 2017-12-14 |
| JP2017536804A5 true JP2017536804A5 (enExample) | 2018-11-08 |
| JP6953308B2 JP6953308B2 (ja) | 2021-10-27 |
Family
ID=54293398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017517301A Expired - Fee Related JP6953308B2 (ja) | 2014-10-02 | 2015-10-01 | インフルエンザａ型ウイルスバリアント |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10801076B2 (enExample) |
| EP (1) | EP3201220A1 (enExample) |
| JP (1) | JP6953308B2 (enExample) |
| KR (1) | KR20170063944A (enExample) |
| CN (1) | CN107002086B (enExample) |
| AU (1) | AU2015325012B2 (enExample) |
| BR (1) | BR112017006680A2 (enExample) |
| CA (1) | CA2963070A1 (enExample) |
| MA (1) | MA40772A (enExample) |
| RU (1) | RU2748618C2 (enExample) |
| WO (1) | WO2016054309A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20207129B (en) | 2009-06-17 | 2020-07-10 | Vertex Pharma | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| PT3068776T (pt) | 2013-11-13 | 2019-08-26 | Vertex Pharma | Inibidores da replicação de vírus da gripe |
| HUE038820T2 (hu) | 2013-11-13 | 2018-11-28 | Vertex Pharma | Eljárás influenzavírusok replikációjának inhibitorai elõállítására |
| MA40773A (fr) * | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus influenza a |
| WO2016183120A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Inhibitors of influenza viruses replication |
| EP3294717B1 (en) | 2015-05-13 | 2020-07-29 | Vertex Pharmaceuticals Inc. | Methods of preparing inhibitors of influenza viruses replication |
| WO2019193428A1 (en) * | 2018-04-06 | 2019-10-10 | Janssen Pharmaceuticals, Inc. | Isothermal reactive crystallisation process for the preparation of a crystalline form of pimodivir hydrochloride hemihydrate |
| WO2020256820A1 (en) * | 2019-06-20 | 2020-12-24 | Janssen Pharmaceuticals, Inc. | Formulations of azaindole compounds |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843701A (en) | 1990-08-02 | 1998-12-01 | Nexstar Pharmaceticals, Inc. | Systematic polypeptide evolution by reverse translation |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| EP1477561B1 (en) | 1996-10-17 | 2008-12-10 | Mitsubishi Chemical Corporation | Molecule assigning genotype to phenotype and use thereof |
| IL131016A (en) | 1997-01-21 | 2004-12-15 | Gen Hospital Corp | Selection of proteins using RNA-protein blends |
| AU5921101A (en) * | 2000-04-28 | 2001-11-12 | St Jude Childrens Res Hospital | Dna transfection system for the generation of infectious influenza virus |
| CA2456292A1 (en) | 2001-08-14 | 2003-02-27 | Toyama Chemical Co., Ltd. | Novel virus growth inhibitor and/or virucidal method, and novel pyrazine nucleotide or pirazine nucleoside analog |
| ES2364340T3 (es) | 2004-03-30 | 2011-08-31 | Vertex Pharmaceuticals Incorporated | Azaindoles útiles como inhibidores de jak y otras proteína quinasas. |
| WO2006050076A1 (en) | 2004-10-29 | 2006-05-11 | Janssen Pharmaceutica, N.V. | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| FI20060200A0 (fi) * | 2005-04-20 | 2006-02-27 | Glykos Finland Oy | Menetelmä ihmisen influenssaviruksen sialihahappositoumisspesifisyyden analysoimiseksi |
| AU2006247322A1 (en) | 2005-05-16 | 2006-11-23 | Irm Llc | Pyrrolopyridine derivatives as protein kinase inhibitors |
| KR20080047355A (ko) * | 2005-07-06 | 2008-05-28 | 바이오칩 이노베이션즈 피티와이 리미티드 | 표적 핵산 서열 분석 방법 및 키트 |
| KR100708593B1 (ko) | 2006-03-23 | 2007-04-18 | 주식회사 고려비엔피 | 발육란 생산성이 우수한 저병원성 ｈ９ｎ２ 아형 조류인플루엔자 바이러스 |
| WO2009125395A1 (en) * | 2008-04-09 | 2009-10-15 | Technion Research & Development Foundation Ltd. | Anti influenza antibodies and uses thereof |
| GEP20207129B (en) | 2009-06-17 | 2020-07-10 | Vertex Pharma | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) * | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| MA40773A (fr) * | 2014-10-02 | 2017-08-08 | Vertex Pharma | Variants du virus influenza a |
-
2015
- 2015-09-30 MA MA040772A patent/MA40772A/fr unknown
- 2015-10-01 JP JP2017517301A patent/JP6953308B2/ja not_active Expired - Fee Related
- 2015-10-01 BR BR112017006680A patent/BR112017006680A2/pt not_active IP Right Cessation
- 2015-10-01 CN CN201580063463.5A patent/CN107002086B/zh not_active Expired - Fee Related
- 2015-10-01 KR KR1020177012203A patent/KR20170063944A/ko not_active Withdrawn
- 2015-10-01 RU RU2017114675A patent/RU2748618C2/ru active
- 2015-10-01 AU AU2015325012A patent/AU2015325012B2/en not_active Ceased
- 2015-10-01 EP EP15779135.1A patent/EP3201220A1/en not_active Withdrawn
- 2015-10-01 CA CA2963070A patent/CA2963070A1/en not_active Abandoned
- 2015-10-01 WO PCT/US2015/053385 patent/WO2016054309A1/en not_active Ceased
-
2017
- 2017-03-31 US US15/475,237 patent/US10801076B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017537605A5 (enExample) | ||
| Álvarez-Buylla et al. | Identification of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? | |
| Okomo‐Adhiambo et al. | Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors | |
| EP2630239B1 (en) | Kit for detecting bovine leukemia virus (blv), and use thereof | |
| RU2017114675A (ru) | Варианты вируса гриппа a | |
| US20210292820A1 (en) | Compositions and methods for detecting and treating sars-cov-2 | |
| JP7855586B2 (ja) | コロナウイルス感染症を発症するリスクが高い対象を特定する方法及びその治療法 | |
| Cotroneo et al. | Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants | |
| JP7084034B2 (ja) | 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法 | |
| US20200216903A1 (en) | Mitochondrial Disease Genetic Diagnostics | |
| JPWO2020032228A5 (enExample) | ||
| CN104313123B (zh) | 一种结核分枝杆菌四种一线药物耐药基因特异片段组合及其应用 | |
| CN103540676B (zh) | 一种检测线粒体基因1555位a-g与1494位c-t突变的试剂盒 | |
| CN116855637B (zh) | 一种检测美洲鳗鲡腺瘤病毒的引物对和试剂盒 | |
| Doumayrou et al. | Mapping genetic determinants of viral traits with FST and quantitative trait locus (QTL) approaches | |
| CN102925555A (zh) | 定性检测人类braf v600e基因突变的测序引物对及其试剂盒 | |
| CN105316350B (zh) | 结核分枝杆菌EmbB突变基因及其用途 | |
| JP4853898B2 (ja) | Ｄｎａ標準物質 | |
| Leisova‐Svobodova et al. | Detection of Garlic Viruses Using SYBR Green Real‐time Reverse Transcription‐Polymerase Chain Reaction | |
| Bergallo et al. | Variants of parvovirus B19: bioinformatical evaluation of nested PCR assays | |
| Sahoo et al. | Diversity of SARS-CoV-2 genome among various strain identified in Lucknow, Uttar Pradesh | |
| KR20130110811A (ko) | 제한효소 절편 질량다형성법을 이용하여 ｈｉｖ에 대한 약제 내성 유전자 돌연변이 검출방법 | |
| KR102942138B1 (ko) | 류마티스 관절염 환자에서 TNF-α 저해제 치료에 따른 피부 부작용 위험 예측용 다형성 마커 및 이를 이용한 류마티스 관절염 환자에서 TNF-α 저해제 치료에 따른 피부 부작용 위험 예측 방법 | |
| Cotroneo et al. | Lung expression of genes encoding SARS-CoV-2 cell entry molecules and antiviral restriction factors: interindividual differences are associated with age and germline variants | |
| JP2013000067A5 (enExample) |